600739.SHG Liaoning Cheng Da Co Ltd
- Market cap
- CNY 15.4B
- P/E
- 9.7x
- P/B
- 0.50x
- ROE
- 9.6%
- Dividend yield
- 4.03%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 600739.SHG undervalued?
Graham number600739.SHG trades 53.6% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Liaoning Cheng Da Co Ltd fundamental analysis
No fundamental analysis for Liaoning Cheng Da Co Ltd yet.
Liaoning Cheng Da Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Liaoning Cheng Da Co Ltd
Liaoning Cheng Da Co., Ltd. engages in pharmaceuticals and healthcare, financial investment, trading, and energy development businesses in China and internationally. The company is involved in the import and export of textiles, and clothing, as well as the trade of bulk commodities, such as coal, steel, and aquatic products; and oil shale mining, shale oil production, and sale business. It also offers financial service enterprises including securities, insurance, and funds; …
Full company profileLiaoning Cheng Da Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Liaoning Cheng Da Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 8.75B | 14.0B | 19.3B | 17.7B | 16.9B | 18.4B | 14.6B | 10.8B | 11.3B | 9.90B | 8.50B |
| Gross Profit | 2.03B | 2.00B | 2.24B | 2.54B | 2.13B | 2.54B | 2.60B | 1.29B | 1.48B | 1.29B | 1.42B |
| Operating Income | 1.40B | 1.88B | 1.03B | 1.47B | 2.33B | 2.64B | 1.72B | 147M | 752M | -85.1M | 122M |
| EBITDA | 617M | 628M | 1.02B | 1.03B | 804M | 1.56B | 1.57B | 296M | 417M | 1.39B | 3.71B |
| Net Income | 948M | 1.45B | 770M | 1.19B | 2.77B | 2.16B | 1.22B | 233M | 210M | 737M | 2.93B |
| EPS | 0.62 | 0.95 | 0.50 | 0.78 | 1.81 | 1.41 | 0.80 | 0.15 | 0.14 | 0.48 | 1.93 |
| Balance Sheet | |||||||||||
| Total Assets | 33.3B | 35.5B | 35.8B | 39.2B | 39.2B | 48.0B | 48.1B | 46.9B | 47.8B | 49.1B | 51.7B |
| Total Liabilities | 13.2B | 14.1B | 14.2B | 16.3B | 14.2B | 16.5B | 15.9B | 15.3B | 15.5B | 16.6B | 17.4B |
| Shareholders' Equity | 18.6B | 20.0B | 20.3B | 21.6B | 24.1B | 28.0B | 28.7B | 28.8B | 29.3B | 28.8B | 30.6B |
| Cash & Short-term Investments | 1.70B | 2.24B | 2.40B | 3.02B | 2.63B | 8.92B | 8.77B | 7.09B | 7.01B | 7.20B | 4.23B |
| Total Debt | 6.77B | 8.71B | 8.67B | 10.7B | 8.82B | 12.1B | 11.6B | 10.4B | 9.99B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 590M | 96.9M | 486M | 880M | 775M | 314M | 1.43B | 647M | 610M | 338M | - |
| Capital Expenditure | 254M | 845M | 500M | 742M | 330M | 614M | 647M | 703M | 455M | 341M | 191M |
| Free Cash Flow | 336M | -748M | -14.3M | 138M | 445M | -300M | 780M | -583M | 155M | -3.24M | 305M |
| Ratios | |||||||||||
| ROE | 5.1% | 7.2% | 3.8% | 5.5% | 11.5% | 7.7% | 4.3% | 0.8% | 0.7% | 2.6% | 9.6% |
| ROA | 2.9% | 4.1% | 2.2% | 3.0% | 7.1% | 4.5% | 2.5% | 0.5% | 0.4% | 1.5% | 5.7% |
| Net Profit Margin | 10.8% | 10.3% | 4.0% | 6.7% | 16.4% | 11.8% | 8.4% | 2.2% | 1.9% | 7.4% | 34.5% |
| Debt to Equity | 0.36x | 0.43x | 0.43x | 0.50x | 0.37x | 0.43x | 0.40x | 0.36x | 0.34x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Liaoning Cheng Da Co Ltd dividends
- Dividend yield
- 4.03%
- Forward dividend
- 0.15 CNY
- Payout ratio
- 84.0%
- Ex-dividend date
- Aug 13, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 619M | 0.40 | 84.0% |
| 2024 | CNY 789M | 0.52 | 376.5% |
| 2023 | CNY 897M | 0.58 | 384.8% |
| 2022 | CNY 1.01B | 0.67 | 82.9% |
| 2021 | CNY 979M | 0.64 | 45.3% |
| 2020 | CNY 726M | 0.47 | 26.2% |
| 2019 | CNY 520M | 0.34 | 43.8% |
| 2018 | CNY 788M | 0.51 | 102.3% |
| 2017 | CNY 508M | 0.33 | 35.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 15:10 on Jul 1, 2011.
Who owns Liaoning Cheng Da Co Ltd
- Insiders 47.11%
- Institutions 2.99%
- Public & others 49.90%
- Shares outstanding 1.52B
- Free float 838M
Liaoning Cheng Da Co Ltd company profile
- Company name
- Liaoning Cheng Da Co Ltd
- Ticker
- 600739.SHG
- ISIN
- CNE000000LY3
- Exchange
- Shanghai Stock Exchange
- Listed since
- Aug 6, 1996
- Sector
- Healthcare
- Industry
- Distributors
- Employees
- 2,740
- Fiscal year end
- December
- Address
- No. 71, Renmin Road, Dalian, China, 116001
- Phone
- 86 411 8251 1111
- Website
- chengda.com.cn
About Liaoning Cheng Da Co Ltd
Liaoning Cheng Da Co., Ltd. engages in pharmaceuticals and healthcare, financial investment, trading, and energy development businesses in China and internationally. The company is involved in the import and export of textiles, and clothing, as well as the trade of bulk commodities, such as coal, steel, and aquatic products; and oil shale mining, shale oil production, and sale business. It also offers financial service enterprises including securities, insurance, and funds; human rabies vaccines and inactivated Japanese encephalitis vaccines; medical industry investment and medical enterprise management consulting; and computer software and hardware technology development, technology consulting, technology transfer, technical services, and selling of medical equipment and other businesses. The company was founded in 1991 and is headquartered in Dalian, China.
Liaoning Cheng Da Co Ltd management
6- Mr. Shanwei ZhangPresident & Director · born 1980
- Ms. Lu WangAccounting Supervisor & CFO · born 1976
- Mr. Heng LiCompliance Director · born 1976
- Mr. Chuang QiuVP & Secretary of the Board · born 1978
- Mr. Yue ZhouVice President · born 1986
- Ms. Peng ZhangHuman Resources Director · born 1975